Patents

Bacterial mutant bx065 and a method thereof

The present invention relates to a mutant bacteria Xanthomonas oryzae pathovar oryzae BXO65 with mutation at a site coding for enzyme shikimate dehydrogenase and a method of producing said mutant and also a method of screening inhibitors of bacterial pathogens with shikimate dehydrogenase pathway to develop bactericides.

Filing Date: 27-03-2002

Issue Date: 22-03-2005

Patent No: US6869601 [USA]

Application No: 109574

Inventor(s): Goel Ajay Kumar; Rajagopal Lakshmi; Sonti Ramesh V

Licensing Option: Laboratory willing to jointly develop technology with industrial partner.

Implementing institute: CSIR-Centre for Cellular and Molecular Biology [CSIR-CCMB]

Funding agency: Council of Scientific and Industrial Research (CSIR)

IPC Classification: A01N 063//00, A01N 065//00, C12N 015//00, C12N 015//01, C12N 001//00

US9550710: Acidic ionic liquids catalyzed depolymerization of lignin

US9487818: Top2A inhibition by temozolomide and its predictive value of GBM patient's survival

US9415442: Stable oxide encapsulated metal clusters and nanoparticles

US9233989: Sila analogs of oxazolidinone derivatives and synthesis thereof

Search form